FDA approves Novo Nordisk's diabetes drug Ozempic for chronic kidney disease, expanding its use
Novo Nordisk(NVO) CNBC·2025-01-29 03:34Novo Nordisk(NVO) CNBC·2025-01-29 03:34
R1Novo Nordisk(NVO) CNBC·2025-01-29 03:34 R1Novo Nordisk(NVO) CNBC·2025-01-29 03:34